---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-189472"
form_type: "8-K"
ticker: null
cik: "0001971543"
company_name: "Mural Oncology plc"
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:33:34.662994+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Mural Oncology appoints George Golumbeski, Ph.D., as independent director

## Summary
- Appointed July 30, 2024; term expires at 2025 annual general meeting.
- Initial option grant of 15,334 shares at $3.38 strike, vesting quarterly over three years.
- Annual cash compensation of $40,000 plus annual equity grants under non-employee director program.
- Board determined Dr. Golumbeski is independent under Nasdaq rules.
- No family relationships or transactions requiring disclosure; standard indemnification agreements.

## SEC filing metadata
- accession: 0001193125-24-189472
- form_type: 8-K
- cik: 0001971543
- company_name: Mural Oncology plc
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971543/000119312524189472/0001193125-24-189472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971543/000119312524189472/d858613d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-189472
- JSON: https://secwatch.observer/filing/0001193125-24-189472.json
- Plain text: https://secwatch.observer/filing/0001193125-24-189472.txt

## Key facts
- Executive change
  George Golumbeski, Ph.D. was appointed as director at Mural Oncology plc.
  - Action: appointed
  - Role: director
  source text: On July 30, 2024, the Board of Directors (the “Board”) of Mural Oncology plc (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, appointed George Golumbeski, Ph.D., as a director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971543/000119312524189472/0001193125-24-189472-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.